Professor Peter John Browett


Selected publications and creative works (Research Outputs)

  • Desai, R., Taghavi, S., Chase, J. C., Chopra, M., Chien, J., Browett, P. J., ... Bohlander, S. K. (2020). Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a and CALM/AF10. Leukemia, 34 (6), 1706-1710. 10.1038/s41375-019-0657-8
    Other University of Auckland co-authors: Rhea Desai, Stefan Bohlander, Purvi Kakadiya
  • Rees, M. J., Spencer, A., Browett, P., Alvaro, F., Purtill, D., Crawford, J., ... Grigg, A. (2020). High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission. Bone marrow transplantation10.1038/s41409-020-0924-3
  • Chien, N., Varghese, C., Green, T. N., Chan, G., Theakston, E., Eaddy, N., ... Browett, P. J. (2020). Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience. Leukemia research, 9310.1016/j.leukres.2020.106358
    Other University of Auckland co-authors: Maggie Kalev
  • Angelucci, E., Li, J., Greenberg, P., Wu, D., Hou, M., Montano Figueroa, E. H., ... Izquierdo, M. (2020). Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes: A Randomized Trial. Annals of internal medicine, 172 (8), 513-522. 10.7326/m19-0916
  • Kulasekararaj, A., Risitano, A., Maciejewski, J., Notaro, R., Browett, P., Lee, J. W., ... Brodsky, R. (2020). A phase 2 open-label study of danicopan (ACH-0144471) in patients with paroxysmal nocturnal haemoglobinuria who have an inadequate response to eculizumab monotherapy. Paper presented at 60th Annual Scientific Meeting of the British-Society-for-Haematology (BSH), Birmingham, ENGLAND. 27 April - 29 April 2020. BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2).
  • van Kan, M., Burns, K. E., Browett, P., & Helsby, N. A. (2019). A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells. Scientific Reports, 910.1038/s41598-019-55161-3
    Other University of Auckland co-authors: Maia van Kan, Katie Burns, Nuala Helsby
  • Molloy, B., Marty Francisco, M., Ellison Misoo, C., Rabitsch, W., Itaelae-Remes, M., Dominietto, A., ... Leavitt Randi, Y. (2019). RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CLINICALLY SIGNIFICANT CYTOMEGALOVIRUS (CMV) INFECTION IN ALLOGENEIC PROGENITOR TRANSPLANTATION. Paper presented at 61st National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy, Valencia, SPAIN. 24 October - 26 October 2019. HAEMATOLOGICA. (pp. 1).
  • Risitano, A., Kulasekararaj, A., Lee, J. W., Notaro, R., Brodsky, R. A., Huang, M., ... Browett, P. (2019). A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH). Paper presented at 47th Congress of the Italian-Society-of-Hematology, Rome, ITALY. 7 October - 9 October 2019. HAEMATOLOGICA. (pp. 1).

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 4, Room 403
New Zealand